Sendero Biotechnology
Rochester
About Sendero Biotechnology
Sendero Biotechnology is a biotechnology company that develops new cancer treatments. It was formed through a partnership with Mayo Clinic. To create better cancer therapies, Sendero Bio licensed technology related to TRAILshort, a recently identified mechanism cancer cells use to evade the immune system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $7.3M
- Last round: Series Unknown (Apr 2023)
- Website: senderobio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Canonical: https://fsome.com/organization/sendero-biotechnology-57720 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.